BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25780066)

  • 41. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
    Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
    J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac screening in infants with infantile hemangiomas before propranolol treatment.
    Blei F; McElhinney DB; Guarini A; Presti S
    Pediatr Dermatol; 2014; 31(4):465-70. PubMed ID: 24889812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary experiences in treating infantile hemangioma with propranolol.
    Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
    Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemangiomas in childhood].
    Schöni MH; Kernland Lang K
    Praxis (Bern 1994); 2011 May; 100(10):575-82, quiz 583-4. PubMed ID: 21563093
    [No Abstract]   [Full Text] [Related]  

  • 45. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
    Chang TC; Estes R
    J AAPOS; 2014 Feb; 18(1):80-2. PubMed ID: 24568991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy.
    Yeh I; Bruckner AL; Sanchez R; Jeng MR; Newell BD; Frieden IJ
    Pediatr Dermatol; 2011; 28(3):267-75. PubMed ID: 21517953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Infantile hemangiomas: the revolution of beta-blockers].
    Leaute-Labreze C
    Rev Prat; 2014 Dec; 64(10):1421-8. PubMed ID: 25665327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Propranolol in the treatment of problematic infantile hemangiomas].
    Lu J; Qin G; Huang J; Li S; Zhao J; Xiang Y; Chen J; Zuo C; Yang S; Tna L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1102-5. PubMed ID: 22169728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
    Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
    Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study.
    Wang L; Wang W; Zhou Z; Li J; Li Z; Lv R; Xu G; Bi J; Huo R
    J Am Acad Dermatol; 2024 Apr; 90(4):783-789. PubMed ID: 38159645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Propranolol use for infantile hemangiomas: American Society of Pediatric Otolaryngology Vascular Anomalies Task Force practice patterns.
    Parikh SR; Darrow DH; Grimmer JF; Manning SC; Richter GT; Perkins JA
    JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):153-6. PubMed ID: 23429945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age.
    Hong P; Tammareddi N; Walvekar R; Chiu ES; Poole JC; Kluka EA; Simon LM
    Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1194-7. PubMed ID: 23706952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful management of airway hemangioma with propranolol.
    Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
    Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
    Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
    Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infantile Hemangiomas: Pathogenesis and Review of Propranolol Use.
    Laken PA
    Adv Neonatal Care; 2016 Apr; 16(2):135-42. PubMed ID: 26945282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Propranolol for Treatment of Genital Infantile Hemangioma.
    Tran C; Tamburro J; Rhee A; Golden A
    J Urol; 2016 Mar; 195(3):731-7. PubMed ID: 26400030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffuse neonatal hemangiomatosis: a case report.
    Martínez-Escanamé M; Castillo-Martínez C; Torres-Álvarez B; González FJ; Oros-Valle C; Moncada B
    Int J Dermatol; 2012 Oct; 51(10):1228-30. PubMed ID: 21470219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.